drugset / Trial / NCT01756833

Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial

NCT01756833

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary aim of this study is to determine if doxycycline (100 mg bid) will inhibit (by at least 40%) the increase in greatest transverse diameter of small abdominal aortic aneurysms (3.5-5.0 cm in men, 3.5-4.5 cm in women) over a 24-month period of observation in comparison to a placebo-treated control group.

Timeline

Start
2013-05
Primary completion
2019-07-23
Completion
2019-07-23

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Doxycycline Small molecule 100 mg Oral

Indications

No indication recorded.